Eversept Partners
Latest statistics and disclosures from Eversept Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NTRA, GSK, TEVA, UTHR, HZNP, and represent 39.88% of Eversept Partners's stock portfolio.
- Added to shares of these 10 stocks: INSP (+$27M), HCA (+$16M), TECH (+$13M), KRYS (+$13M), AMRN (+$13M), ABCM (+$12M), TEVA (+$11M), RGEN (+$8.5M), IFRX (+$8.5M), UTHR (+$8.5M).
- Started 18 new stock positions in KURA, KRYS, CVAC, FGEN, BDTX, WAT, SPRY, AMRN, URGN, Fibrogen. STRO, ABCM, INSP, ELV, APLS, PTGX, MOH, IFRX.
- Reduced shares in these 10 stocks: , HZNP (-$35M), GSK (-$31M), Amarin Corp Plc option (-$22M), NTRA (-$20M), Amedisys Inc. Cmn Stk cmn (-$17M), AVTR (-$15M), BCRX (-$15M), ITCI (-$12M), GH (-$11M).
- Sold out of its positions in Amarin Corp Plc option, Amedisys Inc. Cmn Stk cmn, Anthem Inc opt, AVTR, BIIB, GH, Heska Corporation, ITCI, THC.
- Eversept Partners was a net seller of stock by $-148M.
- Eversept Partners has $966M in assets under management (AUM), dropping by -15.71%.
- Central Index Key (CIK): 0001697013
Tip: Access up to 7 years of quarterly data
Positions held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Eversept Partners
Eversept Partners holds 71 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Natera (NTRA) | 12.2 | $118M | -14% | 2.4M | 48.66 |
|
| GSK Sponsored Adr (GSK) | 10.7 | $104M | -22% | 2.9M | 36.02 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 6.0 | $58M | +23% | 7.7M | 7.53 |
|
| United Therapeutics Corporation (UTHR) | 5.9 | $58M | +17% | 260k | 220.75 |
|
| Horizon Therapeutics Pub L SHS (HZNP) | 5.1 | $49M | -41% | 475k | 102.85 |
|
| Syndax Pharmaceuticals (SNDX) | 4.7 | $46M | 2.2M | 20.93 |
|
|
| Community Health Systems (CYH) | 3.3 | $32M | -19% | 7.3M | 4.40 |
|
| Bio-techne Corporation (TECH) | 2.9 | $28M | +81% | 343k | 81.63 |
|
| Vera Therapeutics Cl A (VERA) | 2.9 | $28M | -2% | 1.7M | 16.05 |
|
| Inspire Med Sys (INSP) | 2.8 | $27M | NEW | 82k | 324.64 |
|
| Celldex Therapeutics Com New (CLDX) | 2.8 | $27M | +13% | 786k | 33.93 |
|
| Danaher Corporation (DHR) | 2.6 | $25M | -30% | 103k | 240.27 |
|
| Hca Holdings (HCA) | 2.5 | $25M | +189% | 81k | 303.48 |
|
| Illumina (ILMN) | 2.4 | $23M | -27% | 124k | 187.49 |
|
| Icon SHS (ICLR) | 1.9 | $18M | -6% | 72k | 250.20 |
|
| BioCryst Pharmaceuticals (BCRX) | 1.7 | $17M | -47% | 2.4M | 7.04 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 1.7 | $16M | 5.3M | 3.10 |
|
|
| Catalent (CTLT) | 1.6 | $16M | -37% | 357k | 43.36 |
|
| Seres Therapeutics (MCRB) | 1.5 | $15M | +21% | 3.1M | 4.79 |
|
| Krystal Biotech (KRYS) | 1.3 | $13M | NEW | 107k | 117.40 |
|
| Amarin Corp Spons Adr New (AMRN) | 1.3 | $13M | NEW | 11M | 1.19 |
|
| Abcam Ads (ABCM) | 1.3 | $12M | NEW | 499k | 24.47 |
|
| Invesco Qqq Tr Put | 1.1 | $10M | -22% | 3.5k | 2968.56 |
|
| Centene Corporation (CNC) | 1.1 | $10M | -47% | 153k | 67.45 |
|
| Ionis Pharmaceuticals (IONS) | 1.0 | $9.9M | -20% | 242k | 41.03 |
|
| Vaxcyte (PCVX) | 1.0 | $9.8M | -34% | 196k | 49.94 |
|
| Taro Pharmaceutical Inds SHS (TARO) | 1.0 | $9.5M | +2% | 250k | 37.93 |
|
| Repligen Corporation (RGEN) | 1.0 | $9.3M | +1068% | 66k | 141.46 |
|
| Inflarx Nv (IFRX) | 0.9 | $8.5M | NEW | 1.9M | 4.46 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.9 | $8.2M | +1409% | 692k | 11.89 |
|
| Model N (MODN) | 0.8 | $7.9M | -7% | 223k | 35.36 |
|
| Spdr S&p 500 Etf Tr Put | 0.8 | $7.5M | -43% | 2.3k | 3273.12 |
|
| Liquidia Corporation Com New (LQDA) | 0.8 | $7.3M | +27% | 925k | 7.85 |
|
| Xenon Pharmaceuticals (XENE) | 0.7 | $6.6M | -15% | 171k | 38.50 |
|
| Molina Healthcare (MOH) | 0.7 | $6.4M | NEW | 21k | 301.24 |
|
| Puma Biotechnology (PBYI) | 0.6 | $5.9M | -14% | 1.7M | 3.53 |
|
| Shockwave Med (SWAV) | 0.6 | $5.7M | -57% | 20k | 285.41 |
|
| Humana (HUM) | 0.6 | $5.3M | -47% | 12k | 448.00 |
|
| Pennant Group (PNTG) | 0.5 | $5.3M | +2% | 432k | 12.28 |
|
| Apellis Pharmaceuticals (APLS) | 0.5 | $5.1M | NEW | 56k | 91.10 |
|
| Kura Oncology (KURA) | 0.5 | $4.8M | NEW | 451k | 10.58 |
|
| Iqvia Holdings (IQV) | 0.4 | $4.2M | +30% | 19k | 224.77 |
|
| eHealth (EHTH) | 0.4 | $4.0M | -59% | 503k | 8.04 |
|
| Medpace Hldgs (MEDP) | 0.4 | $3.7M | +33% | 16k | 240.17 |
|
| Curevac N V (CVAC) | 0.4 | $3.7M | NEW | 357k | 10.42 |
|
| Sutro Biopharma (STRO) | 0.4 | $3.5M | NEW | 748k | 4.65 |
|
| Merus N V (MRUS) | 0.4 | $3.5M | 131k | 26.33 |
|
|
| Agilent Technologies Inc C ommon (A) | 0.4 | $3.4M | +117% | 29k | 120.47 |
|
| Protagonist Therapeutics (PTGX) | 0.3 | $3.2M | NEW | 115k | 27.62 |
|
| Biohaven (BHVN) | 0.3 | $3.1M | -29% | 131k | 23.92 |
|
| Paratek Pharmaceuticals (PRTK) | 0.3 | $2.9M | +107% | 1.3M | 2.21 |
|
| Waters Corporation (WAT) | 0.3 | $2.9M | NEW | 11k | 266.54 |
|
| PerkinElmer (RVTY) | 0.3 | $2.5M | +72% | 21k | 118.79 |
|
| Black Diamond Therapeutics (BDTX) | 0.2 | $2.2M | NEW | 427k | 5.05 |
|
| Gohealth Cl A New (GOCO) | 0.2 | $2.1M | -16% | 105k | 19.71 |
|
| Xoma Corp Del Com New (XOMA) | 0.2 | $1.7M | 90k | 18.89 |
|
|
| Evolus (EOLS) | 0.2 | $1.7M | +3% | 229k | 7.27 |
|
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $1.6M | +8% | 4.2k | 389.73 |
|
| Zai Lab Adr (ZLAB) | 0.2 | $1.5M | -67% | 55k | 27.73 |
|
| Spdr Ser Tr Put | 0.1 | $1.1M | +12% | 900.00 | 1228.96 |
|
| Anthem (ELV) | 0.1 | $1.0M | NEW | 2.3k | 444.29 |
|
| Affimed Therapeutics B V (AFMD) | 0.1 | $1.0M | -10% | 1.7M | 0.60 |
|
| Gossamer Bio (GOSS) | 0.1 | $900k | -44% | 750k | 1.20 |
|
| Aerovate Therapeutics (AVTE) | 0.1 | $862k | 50k | 17.15 |
|
|
| Urogen Pharma (URGN) | 0.1 | $774k | NEW | 75k | 10.35 |
|
| Aadi Bioscience (AADI) | 0.1 | $697k | 102k | 6.84 |
|
|
| Ac Immune Sa SHS (ACIU) | 0.0 | $368k | 125k | 2.96 |
|
|
| Silverback Therapeutics (SPRY) | 0.0 | $327k | NEW | 49k | 6.70 |
|
| Amn Healthcare Svcs Put | 0.0 | $134k | +137% | 950.00 | 141.12 |
|
| Fibrogen Put | 0.0 | $87k | NEW | 388.00 | 223.52 |
|
| Fibrogen (FGEN) | 0.0 | $15k | NEW | 5.6k | 2.70 |
|
Past Filings by Eversept Partners
SEC 13F filings are viewable for Eversept Partners going back to 2017
- Eversept Partners 2023 Q2 filed Aug. 14, 2023
- Eversept Partners 2023 Q1 filed May 15, 2023
- Eversept Partners 2022 Q4 filed Feb. 14, 2023
- Eversept Partners 2022 Q3 filed Nov. 14, 2022
- Eversept Partners 2022 Q2 filed Aug. 15, 2022
- Eversept Partners 2022 Q1 filed May 16, 2022
- Eversept Partners 2021 Q4 filed Feb. 14, 2022
- Eversept Partners 2021 Q3 filed Nov. 15, 2021
- Eversept Partners 2021 Q2 filed Aug. 16, 2021
- Eversept Partners 2021 Q1 filed May 13, 2021
- Eversept Partners 2020 Q4 filed Feb. 16, 2021
- Eversept Partners 2020 Q3 restated filed Nov. 13, 2020
- Eversept Partners 2020 Q3 filed Nov. 12, 2020
- Eversept Partners 2020 Q2 filed Aug. 13, 2020
- Eversept Partners 2020 Q1 filed May 13, 2020
- Eversept Partners 2019 Q4 filed Feb. 13, 2020